“Modulation of Glycemic, Lipid, and HepatorenalBiomarkers by Silymarin Supplementation InType 2 Diabetes Mellitus”. 2025. The Review of Diabetic Studies 21 (1). https://doi.org/10.1900/1z2dn188.